C16 Palmitoyl

C16 Palmitoyl measures palmitoylcarnitine, a long‑chain fatty acid joined to carnitine. Carnitine acts as a shuttle that helps move fatty acids into mitochondria, where they are used to make energy. This compound is one of the acylcarnitines assessed in an acylcarnitine profile.

The test is performed on blood, often by tandem mass spectrometry. It helps evaluate how well your body breaks down long‑chain fats and is commonly used in newborn screening and in the assessment of people with symptoms that could suggest a disorder of fatty acid oxidation.

Abnormal palmitoylcarnitine can point to problems in the carnitine shuttle or long‑chain fatty acid oxidation, such as carnitine palmitoyltransferase II deficiency or carnitine‑acylcarnitine translocase deficiency. Finding these issues early can guide nutrition, medication, and emergency planning to reduce the risk of low blood sugar, muscle breakdown, or heart complications during stress or illness.

Clinicians usually order this test along with other acylcarnitines and carnitine measurements, and interpret it in the context of symptoms, exam findings, and other labs. Certain medications, supplements, and nutrition support can shift results, so your care team considers these factors when deciding on next steps.

A higher palmitoylcarnitine level can be seen in some long‑chain fatty acid oxidation disorders, but it is not diagnostic on its own. Your clinician may repeat testing, review the full acylcarnitine pattern, and, if needed, arrange confirmatory studies such as enzyme or genetic testing. A low or uninterpretable result can occur with low carnitine stores, treatment effects, or specimen issues.

If results are outside the expected range, your care team will discuss what that could mean for you and whether to adjust diet, avoid prolonged fasting, or create an illness plan. For infants, follow‑up is typically coordinated with a metabolic specialist to confirm the cause and begin appropriate management.